Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Associated Wealth Advisors Launches the “The 10-Billion Fund Showdown” to Select Visionary Leadership for Its Landmark Project
-
CareCloud Announces Acquisition of HFMA’s MAP App to Expand AI-Driven Benchmarking in Hospitals and Integrated Health Systems
-
Rezolve Ai Clarifies Recent SEC Filing and Reaffirms Strategic Growth Initiatives
-
Oxbridge / SurancePlus to Attend TOKEN2049 Singapore
-
Southern Realty Trust Commits $10.0 Million to a $370.0 Million First Mortgage Loan for the Financing of the Lofty & Standard in Miami, FL
-
INmune Bio Announces Submission of Phase 2 MINDFuL Trial Results in Alzheimer’s Disease to npj Dementia, a Nature Portfolio Journal
-
GlobalFoundries and Corning Collaborate To Deliver Detachable Fiber Connector Solutions to Scale Next-Generation Optical Connectivity
-
HF Foods Group Announces Agreement to Acquire Chicago Distribution Facility
-
Sunrise Realty Trust Commits $35.0 Million to a $370.0 Million First Mortgage Loan for the Financing of the Lofty & Standard in Miami, FL
-
Apollo Announces Launch of Apollo Sports Capital
-
KALA BIO Announces Topline Results from CHASE Phase 2b Clinical Trial Evaluating KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED) Did Not Meet Primary Endpoint
-
NBCUniversal and DraftKings Enter Multi-Year Collaboration Across Expansive Sports Portfolio
-
Aeries Technology Projects $20M+ Run-Rate by Fiscal Year-End on Two Enterprise Wins; Adding 500+ Roles Across India and Mexico
-
Hyperion DeFi Announces Appointment of David Knox as Chief Financial Officer
-
Rocket Doctor AI to Present at the 2025 CANTech Letter Conference in Toronto
-
Village Farms International’s Board of Directors Unanimously Approves $10 Million Share Repurchase Authorization
-
MindRank Announces Positive 12-week Once-Daily (QD) Results for AI-Designed Oral GLP-1 Agonist MDR-001 in Adults with Obesity
-
Provectus Biopharmaceuticals Initiates Preclinical Study of Oral PV-10 in Bladder Cancer
-
Calidi Biotherapeutics to Present at the second annual Oncology Venture, Innovation, and Partnering Summit in Boston
-
Kratos Completes Preliminary Design Review for Space Development Agency’s Advanced Fire Control Ground Integration (AFCGI) System
-
Levy to Succeed Krinick as Rivkin Radler Managing Partner
-
The Oncology Institute Partners with Protocol Behavioral Health to Integrate Mental Health Services into Cancer Care
-
Neura Health Secures $11.4 Million Series A to Fuel National Expansion of Comprehensive, Tech-Enabled Neurology Care Model
-
Lisata Therapeutics Announces Encouraging Preliminary Results from the Pancreatic Cancer Cohort of the CENDIFOX Trial
-
Elicio Therapeutics Announces Investigator-Initiated Phase 1 Trial to be Conducted by Memorial Sloan Kettering Cancer Center and funded by The Lustgarten Foundation for Neoadjuvant ELI-002 7P in Pancr
-
NeenOpal Launches GAfix: A Smarter Way to Audit Google Analytics
-
Lumanity Introduces Groundbreaking Value Framework to Transform Biopharma Commercialization
-
FAVO Capital Appoints Dr. Wael Barsoum as Independent Director
-
MBX Biosciences to Participate in the Stifel 2025 Virtual Cardiometabolic Forum
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PERSONAL FINAN - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - GREENCORE GROUP PLC - Ordinary Shares
-
Official Philips Home Access Online Store Has Been Launched — Up to 60 % OFF, Free Shipping and Exclusive Giveaways
-
Graphenix Development and the Energy Storage Engine Power Upstate NY’s Battery Ecosystem
-
Short Term Installment Loans: RadCred Launches User-Friendly Platform for Quick Approval Bad Credit Loans in 2025
-
Asante Announces Start of Bibiani Sulphide Plant Operation
-
Novartis announces commencement of tender offer to acquire Tourmaline Bio
-
Quantum BioPharma Ltd. Announces Results of Annual General and Special Meeting of Shareholders
-
Veriff named a Leader in G2’s Identity Verification Grid® Report
-
Odyssey Resources Provides Update on Upcoming Annual General and Special Meeting of Shareholders
-
Phillips Edison & Company Inc. Invites You to Join Its Third Quarter 2025 Earnings Conference Call
-
FTI Consulting Adds Regulatory Compliance Expert James Needham to Export Controls, Sanctions & Trade Practice
-
Change to North Media’s Group Executive Board and to the Chairman’s planned resignation
-
Cytokinetics Presents New Data Related to Aficamten at the HFSA Annual Scientific Meeting 2025
-
FTI Consulting Adds Regulatory Compliance Expert James Needham to Export Controls, Sanctions & Trade Practice
-
PharmaCorp Rx Inc. Files Preliminary Short Form Base Shelf Prospectus
-
Phillips Edison & Company Inc. Invites You to Join Its Third Quarter 2025 Earnings Conference Call
-
Altimmune Appoints Industry Veteran Christophe Arbet-Engels, M.D., PhD as Chief Medical Officer to Drive Next Phase of Clinical Development of Pemvidutide
-
NextGen Digital Platforms Inc. Reiterates its Strategic Plan to Build Long-Term Value by Bridging Traditional Capital Markets with Web3 Infrastructure
-
HM Exploration Acquires High Grade Copper VMS Project in Newfoundland
-
Matador Technologies Inc. Provides U.S. Listing and Leadership Update
